KRAS, NRAS, PIK3CA Exon 20, and BRAF Genotypes in Synchronous and Metachronous Primary Colorectal Cancers: Diagnostic and Therapeutic Implications
作者： Katharina Balschun , Jochen Haag , Ann-Kathrin Wenke , Witigo von Schönfels , Nicolas T. Schwarz
DOI: 10.1016/J.JMOLDX.2011.03.002
关键词:
摘要: … and one had a distant lymph node metastasis. Genomic DNA … The tumor-node-metastasis (TNM) stage was determined … However, patients 16 and 17 had two and three distinct primary …
jmdjournal.org
unirioja.es参考文章(41)
S. Wallinger, W. Dietmaier, F. Hofstädter, F. Kullmann, J. Rüschoff, A. Beham, T. Bocker, Molekulare Krebsdispositionsdiagnostik am Beispiel des kolorektalen Karzinoms**Welchen Beitrag kann die Pathologie leisten? Pathologe. ,vol. 19, pp. 269- 278 ,(1998) , 10.1007/S002920050283
Werner Scheithauer, Alois Lang, Thomas Winder, K-ras mutations and cetuximab in colorectal cancer. The New England Journal of Medicine. ,vol. 360, pp. 834- 834 ,(2009)
Joachim Messing, New M13 vectors for cloning. Methods in Enzymology. ,vol. 101, pp. 20- 78 ,(1983) , 10.1016/0076-6879(83)01005-8
Zacharenia Saridaki, Vassilis Georgoulias, John Souglakos, Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer World Journal of Gastroenterology. ,vol. 16, pp. 1177- 1187 ,(2010) , 10.3748/WJG.V16.I10.1177
Mohamed Bouchahda, Abdoulaye Karaboué, Raphaël Saffroy, Pasquale Innominato, Lee Gorden, Catherine Guettier, René Adam, Francis Lévi, Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis. Cancer Chemotherapy and Pharmacology. ,vol. 66, pp. 605- 609 ,(2010) , 10.1007/S00280-010-1298-9
Carla Oliveira, S Velho, C Moutinho, A Ferreira, A Preto, E Domingo, AF Capelinha, A Duval, Richard Hamelin, JC Machado, S Schwartz, F Carneiro, R Seruca, None, KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression Oncogene. ,vol. 26, pp. 158- 163 ,(2007) , 10.1038/SJ.ONC.1209758
B�n�dicte Baisse, Hanifa Bouzourene, Emilia P. Saraga, Fred T. Bosman, Jean Benhattar, Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. International Journal of Cancer. ,vol. 93, pp. 346- 352 ,(2001) , 10.1002/IJC.1343
Paloma Cejas, Miriam Lopez-Gomez, Cristina Aguayo, Rosario Madero, Javier de Castro Carpeno, Cristobal Belda-Iniesta, Jorge Barriuso, Victor Moreno Garcia, Javier Larrauri, Rocío López, Enrique Casado, Manuel Gonzalez-Baron, Jaime Feliu, None, KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis. PLOS ONE. ,vol. 4, pp. 8199- ,(2009) , 10.1371/JOURNAL.PONE.0008199
W. J. Cunliffe, P. S. Hasleton, D. E. F. Tweedle, P. F. Schofield, Incidence of synchronous and metachronous colorectal carcinoma. British Journal of Surgery. ,vol. 71, pp. 941- 943 ,(2005) , 10.1002/BJS.1800711210
Shuji Ogino, Takako Kawasaki, Mohan Brahmandam, Liying Yan, Mami Cantor, Chungdak Namgyal, Mari Mino-Kenudson, Gregory Y. Lauwers, Massimo Loda, Charles S. Fuchs, Sensitive Sequencing Method for KRAS Mutation Detection by Pyrosequencing The Journal of Molecular Diagnostics. ,vol. 7, pp. 413- 421 ,(2005) , 10.1016/S1525-1578(10)60571-5